13G Filing: Deerfield Management Reveals 5% Stake in Newly-Public Editas Medicine, Inc. (EDIT)

CUSIP No.

28106W103

13G

Page 8 of 11


Item 1(a).		Name of Issuer:

		Editas Medicine, Inc.

Item 1(b).		Address of Issuer’s Principal Executive Offices:

		300 Third Street, First Floor Cambridge, MA 02142

Item 2(a).		Name of Person Filing:

		James E. Flynn, Deerfield Mgmt HIF, L.P., Deerfield Mgmt III, L.P., Deerfield Management Company, L.P., Deerfield Healthcare Innovations Fund, L.P. and Deerfield Private Design Fund III, L.P.

Item 2(b).		Address of Principal Business Office, or if None, Residence:

		James E. Flynn, Deerfield Mgmt HIF, L.P., Deerfield Mgmt III, L.P., Deerfield Management Company, L.P., Deerfield Healthcare Innovations Fund, L.P. and Deerfield Private Design Fund III, L.P., 780 Third Avenue, 37th Floor, New York, NY 10017

Item 2(c).		Citizenship:

		Deerfield Mgmt HIF, L.P., Deerfield Mgmt III, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund III, L.P. and Deerfield Healthcare Innovations Fund, L.P. – Delaware limited partnerships; James E. Flynn – United States citizen

Item 2(d).		Title of Class of Securities:

		Common Stock, $0.0001 par value per share

Item 2(e).		CUSIP Number:

		28106W103

Item 3.		If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

(a)	o	Broker or dealer registered under Section 15 of the Exchange Act.

(b)	o	Bank as defined in Section 3(a)(6) of the Exchange Act.

(c)	o	Insurance company as defined in Section 3(a)(19) of the Exchange Act.

(d)	o	Investment company registered under Section 8 of the Investment Company Act.

(e)

o

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);


(f)		o	An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

(g)

o

A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);


(h)		o	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

Page 7 of 13 SEC Filing